Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting :

Información:
Discusión (0)
Estadísticas de uso

Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting : PROTEC - Berger, Thomas (Universitätsklinik für Neurologie) ; Brochet, B. (Groupe Hospitalier Pellegrin Hôpital Pellegrin) ; Brambilla, L. (IRCCS Foundation Neurological Institute Carlo Besta) ; Giacomini, P.S. (Montreal Neurological Institute Hospital) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Vasco Salgado, A (Hospital Professor Doutor Fernando Fonseca) ; Su, R (Biogen, USA) ; Bretagne, A (Biogen International GmbH) ; Universitat Autònoma de Barcelona. Departament de Medicina

Comentarios (0) | Reseñas (0)

Inicie un debate sobre cualquier aspecto de este documento.

Registros similares

Añadir comentario